Remnant Lipoproteins as a Target for Atherosclerosis Risk Reduction

Arterioscler Thromb Vasc Biol. 2021 Jun;41(6):2076-2079. doi: 10.1161/ATVBAHA.121.316341. Epub 2021 May 6.

Author

Michael G Levin¹

Affiliation

¹ Division of Cardiovascular Medicine, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia.

PMID: 33951940
DOI: 10.1161/ATVBAHA.121.316341

No abstract available

Keywords: Editorials; atherosclerosis; cardiovascular disease; cholesterol; lipoprotein; risk.

Publication types

Editorial
Comment

MeSH terms

Atherosclerosis* / epidemiology
Atherosclerosis* / prevention & control
Humans
Lipoproteins*
Risk Reduction Behavior

Substances

Lipoproteins